Is Cotrimoxazole the Same as Trimethoprim?
No, cotrimoxazole is not the same as trimethoprim—cotrimoxazole is a combination antibiotic containing both trimethoprim AND sulfamethoxazole (also called co-trimoxazole or trimethoprim-sulfamethoxazole), whereas trimethoprim is a single antibiotic agent that can be used alone. 1, 2
Key Differences
Cotrimoxazole is a fixed-dose combination drug containing trimethoprim and sulfamethoxazole in a 1:5 ratio (typically 160 mg trimethoprim with 800 mg sulfamethoxazole in standard adult dosing). 3, 4 The combination was developed in the late 1960s based on the theory that combining these two agents would produce synergistic antimicrobial effects and delay resistance development. 5, 6
Trimethoprim alone is a single antibiotic that blocks bacterial dihydrofolate reductase, inhibiting folate synthesis and thereby bacterial DNA production. 3 It can be prescribed as monotherapy for many infections where cotrimoxazole has traditionally been used. 5, 6
Clinical Implications
When Trimethoprim Alone Is Sufficient
For most common urinary tract infections and respiratory tract infections, trimethoprim alone is equally effective as cotrimoxazole. 5, 6 Clinical trials have consistently failed to demonstrate superiority of the combination over trimethoprim monotherapy for these indications. 5, 6, 7
Using trimethoprim alone reduces adverse effects because you avoid the sulfonamide component, which is responsible for most of cotrimoxazole's toxicity including Stevens-Johnson syndrome, toxic epidermal necrolysis, and serious hematologic reactions. 8, 5, 6
When the Combination (Cotrimoxazole) Is Necessary
Cotrimoxazole should be specifically chosen over trimethoprim alone for:
- Pneumocystis jirovecii pneumonia (the primary indication where combination therapy is proven superior) 5, 6, 9, 10
- Toxoplasmosis 5
- Nocardiosis 1, 9
- Brucellosis 5, 9
- Stenotrophomonas maltophilia infections 9
- Burkholderia infections 9
- Certain protozoal infections (Cyclospora, Isospora) 9
Pharmacokinetic Distinctions
The two drugs have different tissue distribution patterns. Trimethoprim achieves higher concentrations in sputum and bronchial secretions than sulfamethoxazole, which is often undetectable in these sites. 7 Both components are primarily renally eliminated, with mean half-lives of 8-10 hours for trimethoprim and 10 hours for sulfamethoxazole. 3, 4
Approximately 44% of trimethoprim and 70% of sulfamethoxazole are protein-bound, and the presence of sulfamethoxazole does not significantly affect trimethoprim's protein binding. 3, 4
Safety Considerations
The adverse effect profile of cotrimoxazole represents a summation of both components' toxicities. 5, 6 The sulfonamide component adds risks of:
- Severe cutaneous reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis) 8, 2
- Hematologic toxicity (agranulocytosis, aplastic anemia, thrombocytopenia) 8
- Hepatotoxicity 8
- Hyperkalemia 1, 8
When prescribing cotrimoxazole with methotrexate, the combination significantly increases bone marrow suppression risk because both trimethoprim and sulfamethoxazole are antifolate agents. 11 This interaction is particularly dangerous in elderly patients with renal impairment. 11
Dosing Distinctions
Cotrimoxazole dosing is expressed as the trimethoprim component: standard treatment doses range from 15-20 mg/kg/day of trimethoprim (which corresponds to 75-100 mg/kg/day of the combination). 12, 10 For Pneumocystis pneumonia prophylaxis, lower doses are used. 13, 10
Trimethoprim alone is typically dosed at 200 mg twice daily for respiratory infections or 100-200 mg daily for urinary tract infections. 7
Common Pitfall
The most critical error is using cotrimoxazole when trimethoprim alone would suffice, thereby exposing patients to unnecessary sulfonamide-related toxicity without clinical benefit. 5, 6 For routine urinary and respiratory tract infections in immunocompetent patients, trimethoprim monotherapy should be strongly preferred unless specific pathogens requiring the combination are suspected or confirmed. 5, 6